Incisions: Well healed  Pertinent Results: On Admission: [**2136-6-22**] WBC-7.8 RBC-2.78* Hgb-9.7* Hct-28.5* MCV-103* MCH-35.0*# MCHC-34.2 RDW-14.4 Plt Ct-264 PT-15.0* PTT-33.4 INR(PT)-1.3* Glucose-95 UreaN-45* Creat-7.7*# Na-135 K-3.9 Cl-92* HCO3-27 AnGap-20 Calcium-9.1 Phos-2.5* Mg-2.3 On Discharge:[**2136-7-9**] WBC-6.3 RBC-2.83* Hgb-9.0* Hct-27.5* MCV-97 MCH-31.7 MCHC-32.7 RDW-18.3* Plt Ct-279 PT-33.2* PTT-36.7* INR(PT)-3.6* Glucose-78 UreaN-29* Creat-6.6*# Na-134 K-4.1 Cl-100 HCO3-24 AnGap-14 Calcium-8.2* Phos-2.7 Mg-2.4  Brief Hospital Course: Patient admitted with infected femoral hemodialysis catheter.
CT examination of the abdomen and pelvis revealed no suspicious areas of abscess collection.
An ECHO was performed and ruled out endocarditis, showing Normal study, No valvular pathology or pathologic flow identified.
Blood cultures drawn daily, the ones from [**6-24**] grew Staph Coag Positive and an ID consult was called.
Gentamycin was taken off regimen and daily blood cultures were followed, which have all been no growth since initial positive culture.
She received a bolus and was otherwise okay, ECG was WNL in sinus.
She started on a heparin drip and was subsequently converted to Warfarin therapy with goal inr of 2.0 to 2.5.
Seen by Cardiology; ECHO performed on [**7-4**] showing "Compared with the prior study (images reviewed) of [**2136-6-25**], the findings are similar.
Biventricular systolic function remains normal and no intracardiac thrombi are seen."
Repeat CT on [**7-4**] did not show any abdominal fluid collections.
Medications on Admission: ChlorproMAZINE 100 mg PO QHS, Lisinopril 20', Cinacalcet 90', Metoprolol 50", Clonazepam 0.75", Metoclopramide 5''', colace 100", nIFEdipine 10 QHD, Epoetin Alfa, Nephrocaps T', Fluphenazine 62.5 mg IM/SC QTues, Ropinirole 1.5', Fluphenazine 5 mg PO QAM, Fluphenazine 10 mg PO QPM, Tiotropium Bromide 1 CAP IH DAILY, Foate T", Lanthanum 1000'''   Discharge Medications: 1.
Aluminum-Magnesium Hydroxide 225-200 mg/5 mL Suspension Sig: 15-30 MLs PO QID (4 times a day) as needed.
Followup Instructions: [**First Name4 (NamePattern1) 4850**] [**Last Name (NamePattern1) **] (Infectious Disease) [**2140-8-2**]:00 AM.
